Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.62 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.58 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.57 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.57 |
| ▸ | TGM2 | P21980 | 1/20 | 0.55 |
| ▸ | ANPEP | P15144 | 1/20 | 0.55 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.54 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.54 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.53 |
| ▸ | DPP4 | P27487 | 1/20 | 0.53 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6374328 | 0.99 | HTT (0.60) | HTTSLC1A3SLC1A1LMNASMN1; SMN2 | |
| SCHEMBL3181613 | 0.96 | DPP8 (0.61) | HTTSLC1A3SLC1A1LMNASMN1; SMN2 | |
| SCHEMBL2033858 | 0.96 | DPP8 (0.61) | HTTSLC1A3SLC1A1LMNASMN1; SMN2 | |
| SCHEMBL2032072 | 0.96 | DPP8 (0.61) | HTTSLC1A3SLC1A1LMNASMN1; SMN2 | |
| SCHEMBL2228405 | 0.95 | DPP8 (0.60) | HTTSLC1A3SLC1A1LMNASMN1; SMN2 | |
| SCHEMBL1586589 | 0.89 | HTT (0.62) | HTTSLC1A3SLC1A1LMNASMN1; SMN2 | |
| SCHEMBL1586590 | 0.89 | HTT (0.62) | HTTSLC1A3SLC1A1LMNASMN1; SMN2 | |
| SCHEMBL31295310 | 0.88 | HTT (0.64) | HTTSLC1A3SLC1A1LMNASMN1; SMN2 | |
| SCHEMBL13995289 | 0.86 | HTT (0.58) | HTTSLC1A3SLC1A1LMNASMN1; SMN2 | |
| SCHEMBL1586919 | 0.85 | DPP8 (0.61) | HTTSLC1A3SLC1A1LMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130022628-A1 | ACYL PSEUDOPEPTIDES WHICH CARRY A FUNCTIONALIZED AUXILIARY ARM | OM PHARMA (CH) | 2013-01-24 | — | — | US | claimed |
| EP-3842437-A1 | HIGH ACTIVITY STING PROTEIN AGONIST | Adlai Nortye Biopharma Co., Ltd. (CN) | 2021-06-30 | — | — | EP | disclosed |
| US-20130022628-A1 | ACYL PSEUDOPEPTIDES WHICH CARRY A FUNCTIONALIZED AUXILIARY ARM | OM PHARMA (CH) | 2013-01-24 | — | — | US | disclosed |
| US-20050192232-A1 | Novel acyl-dipeptide-like compounds bearing an accessory functional side chain spacer, a method for preparing the same and pharmaceutical compositions containing such products | OM PHARMA (CH) | 2005-09-01 | — | — | US | disclosed |
| CN-1434795-A | Acylated Pseudodipeptides with Functionalized Auxiliary Branches | OM PHARMA (CH) | 2003-08-06 | — | — | CN | disclosed |
| EP-1242365-A1 | ACYL PSEUDODIPEPTIDES WHICH CARRY A FUNCTIONALISED AUXILIARY ARM | OM Pharma (CH) | 2002-09-25 | — | — | EP | disclosed |
| WO-2001046126-A1 | ACYL PSEUDODIPEPTIDES WHICH CARRY A FUNCTIONALISED AUXILIARY ARM | OM PHARMA (CH) | 2001-06-28 | — | — | WO | disclosed |
| WO-2001046127-A1 | ACYL PSEUDOPEPTIDES BEARING A FUNCTIONALISED AUXILIARY SPACER | OM PHARMA (CH) | 2001-06-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050192232-A1 | Novel acyl-dipeptide-like compounds bearing an accessory functional side chain spacer, a method for preparing the same and pharmaceutical compositions containing such products | PIGS, AADAT, CD74 | HTT 3254/4885SLC1A3 637/4885SLC1A1 510/4885 |
| US-20130022628-A1 | ACYL PSEUDOPEPTIDES WHICH CARRY A FUNCTIONALIZED AUXILIARY ARM | PIGS, ENPEP, DNPEP | HTT 2783/4885SLC1A3 1273/4885SLC1A1 1143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.